市場調查報告書
商品編碼
1577101
2030 年永續藥品包裝市場預測:按產品、材料、應用、最終用戶和地區進行的全球分析Sustainable Pharmaceutical Packaging Market Forecasts to 2030 - Global Analysis By Product (Primary Packaging, Secondary Packaging, Tertiary Packaging and Other Products), Material, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球永續藥品包裝市場規模為 756.2 億美元,預計預測期內複合年成長率為 17.5%,到 2030 年將達到 1,508.6 億美元。
永續藥品包裝是指設計和生產包裝解決方案,最大限度地減少對環境的影響,同時確保藥品的安全性、有效性和品質。永續藥品包裝也著重於最佳化包裝尺寸和設計,以最大限度地減少材料使用並提高可回收性。
根據歐洲製藥工業聯合會和協會的數據,2021年北美佔全球藥品銷售額的佔有率為49.1%,歐洲為23.4%。
企業永續性目標不斷提高
製藥公司正在將永續性納入其業務策略,以滿足相關人員的期望、遵守法規並提高品牌聲譽。我們的目標是透過使用環保包裝解決方案(包括可回收材料和生物分解性選項)來減少碳排放並最大限度地減少廢棄物。這種轉變不僅吸引了具有環保意識的消費者,也促進了包裝設計和材料的創新。因此,企業永續性目標與市場需求之間的一致性將推動製藥業永續包裝解決方案的成長。
監管障礙
永續藥物包裝的監管障礙通常來自於管理藥物包裝材料的嚴格準則,以確保安全性、有效性和符合健康標準。這些法規可能因地區而異,從而使新的永續材料的核准流程變得複雜。此外,「永續」的定義並不標準化,這可能會導致製造商之間的混淆。這些挑戰增加了產品開發成本並延長了時間,阻礙了市場開拓。
先進材料科學與封裝技術
生物分解性聚合物、植物來源材料和智慧包裝解決方案等創新增強了包裝的功能性和環保性能。這些材料提高了阻隔性能,確保產品的安全性和有效性,同時環保。此外,3D 列印等技術可以創建客製化且高效的包裝設計,並最大限度地減少材料浪費。這種先進的包裝符合監管要求和消費者偏好,從而支持製藥業採用永續包裝解決方案。
供應鏈挑戰
永續藥品包裝的供應鏈挑戰包括採購環保材料、控制成本和確保品質穩定。永續材料的供應有限可能會擾亂生產計劃,而與傳統包裝相比更高的成本可能會阻礙製藥公司的採用。此外,永續材料回收過程和物流的複雜性可能導致效率低下。這些挑戰可能會阻礙市場成長,並最終影響競爭力,使公司難以過渡到永續實踐。
COVID-19 的影響
COVID-19 大流行對永續藥品包裝市場產生了重大影響,加速了對環保解決方案的需求。對健康和安全的日益關注提高了人們對包裝在防止污染方面作用的認知,導致一次性產品的激增。然而,這場危機促使製藥公司優先考慮永續性,因為供應鏈中斷凸顯了復原能力的必要性。向電子商務的轉變進一步推動了永續包裝的市場開拓,以滿足消費者對環保產品的偏好,並推動市場的長期成長。
預計疫苗產業在預測期內將是最大的產業。
預計疫苗領域將在整個預測期內獲得最大的市場佔有率。疫苗應用的永續藥物包裝對於確保產品完整性並盡量減少對環境的影響至關重要。環保包裝材料,包括可回收和生物分解性的材料,擴大用於維持低溫運輸並防止疫苗劣化。隨著疫苗宣傳活動在全球擴大,採用永續包裝解決方案不僅支持環境目標,也增強了大眾對製藥業的信任。
預計生質塑膠產業在預測期內複合年成長率最高
預計生質塑膠產業在預測期內的複合年成長率最高。由於其環保特性和減少對傳統塑膠依賴的潛力,使用生質塑膠的永續藥品包裝正在取得進展。生質塑膠源自可再生資源,具有生物分解性並減少碳足跡。隨著製藥公司越來越重視永續性,生質塑膠提供了一種可行的替代方案,使包裝實踐與環境目標和消費者對醫療保健領域更綠色解決方案的需求保持一致。
由於消費者對環境問題的意識不斷提高以及永續商業實踐的監管壓力不斷加大,預計亞太地區將在預測期內創下最大的市場佔有率。日本、中國和印度等國家在採用環保包裝解決方案方面處於領先地位,包括生物分解性材料和可回收材料。該地區強勁的製藥業,加上包裝技術的進步,進一步支持了這一趨勢。此外,隨著公司努力提高品牌聲譽並滿足消費者對綠色產品不斷變化的需求,COVID-19 大流行加速了向永續實踐的轉變。
由於嚴格的法規,預計北美在預測期內的複合年成長率最高。美國和加拿大處於採用永續實踐的前沿,製藥公司專注於可回收材料、生物分解性包裝和減少對環境影響的創新設計。企業永續性努力和對高效供應鏈解決方案的需求進一步推動了市場。此外,COVID-19 大流行加速了對永續性的關注,促使公司根據消費者對環保產品不斷變化的偏好來加強其包裝策略。
According to Stratistics MRC, the Global Sustainable Pharmaceutical Packaging Market is accounted for $75.62 billion in 2024 and is expected to reach $150.86 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Sustainable pharmaceutical packaging refers to the design and production of packaging solutions that minimize environmental impact while ensuring the safety, efficacy, and quality of pharmaceutical products. Sustainable pharmaceutical packaging also focuses on optimizing packaging size and design to minimize material use and enhance recyclability.
According to the European Federation of Pharmaceutical Industries and Association, in 2021, North America's share of world pharmaceutical sales was 49.1%, while Europe's share was 23.4%.
Rising corporate sustainability goals
Pharmaceutical firms are integrating sustainability into their business strategies to meet stakeholder expectations, comply with regulations, and enhance brand reputation. By adopting eco-friendly packaging solutions, such as recyclable materials and biodegradable options, they aim to reduce their carbon footprint and minimize waste. This shift not only attracts environmentally conscious consumers but also fosters innovation in packaging design and materials. Consequently, the alignment of corporate sustainability goals with market demands propels the growth of sustainable packaging solutions in the pharmaceutical sector.
Regulatory hurdles
Regulatory hurdles in sustainable pharmaceutical packaging often arise from the stringent guidelines governing materials used in drug packaging, ensuring safety, efficacy, and compliance with health standards. These regulations can vary significantly across regions, complicating the approval process for new sustainable materials. Additionally, the lack of standardized definitions for "sustainable" can create confusion among manufacturers. These challenges can lead to increased costs and extended timelines for product development, hampering market growth.
Advancements in materials science and packaging technologies
Innovations such as biodegradable polymers, plant-based materials, and smart packaging solutions enhance the functionality and environmental performance of packaging. These materials offer improved barrier properties, ensuring product safety and efficacy while being eco-friendly. Additionally, technologies like 3D printing enable the creation of customized, efficient packaging designs that minimize material waste. As these advancements align with regulatory requirements and consumer preferences, they drive widespread adoption of sustainable packaging solutions in the pharmaceutical sector.
Supply chain challenges
Supply chain challenges in sustainable pharmaceutical packaging include sourcing eco-friendly materials, managing costs, and ensuring consistent quality. The limited availability of sustainable materials can disrupt production schedules, while higher costs compared to conventional packaging can deter adoption among pharmaceutical companies. Additionally, complexities in recycling processes and logistics for sustainable materials may lead to inefficiencies. These challenges can hamper market growth by making it difficult for companies to transition to sustainable practices, ultimately affecting their competitiveness.
Covid-19 Impact
The covid-19 pandemic significantly impacted the sustainable pharmaceutical packaging market by accelerating the demand for environmentally friendly solutions. Increased focus on health and safety heightened awareness of packaging's role in preventing contamination, leading to a surge in single-use products. However, the crisis also prompted pharmaceutical companies to prioritize sustainability, as supply chain disruptions highlighted the need for resilience. The shift toward e-commerce further encouraged the development of sustainable packaging to meet consumer preferences for eco-friendly products, driving long-term growth in the market.
The vaccines segment is expected to be the largest during the forecast period
The vaccines segment is predicted to secure the largest market share throughout the forecast period. Sustainable pharmaceutical packaging in vaccine applications is critical for ensuring product integrity while minimizing environmental impact. Eco-friendly packaging materials, such as recyclable and biodegradable options, are increasingly used to maintain the cold chain and protect vaccines from degradation. As vaccination campaigns expand globally, the adoption of sustainable packaging solutions not only supports environmental goals but also reinforces public trust in the pharmaceutical industry.
The bioplastics segment is expected to have the highest CAGR during the forecast period
The bioplastics segment is anticipated to witness the highest CAGR during the forecast period. Sustainable pharmaceutical packaging using bioplastics is gaining traction due to its environmentally friendly properties and potential to reduce reliance on conventional plastics. Bioplastics, derived from renewable sources offer biodegradability and reduced carbon footprints. As pharmaceutical companies increasingly prioritize sustainability, bioplastics present a viable alternative, aligning packaging practices with environmental goals and consumer demand for greener solutions in the healthcare sector.
Asia Pacific is expected to register the largest market share during the forecast period driven by rising consumer awareness of environmental issues and increasing regulatory pressure for sustainable practices. Countries like Japan, China, and India are leading the way in adopting eco-friendly packaging solutions, including biodegradable materials and recyclable options. The region's robust pharmaceutical industry, coupled with technological advancements in packaging, further fuels this trend. Additionally, the COVID-19 pandemic has accelerated the shift towards sustainable practices, as companies strive to enhance their brand reputation and meet evolving consumer demands for greener products.
North America is projected to witness the highest CAGR over the forecast period due to stringent regulations. The United States and Canada are at the forefront of adopting sustainable practices, with pharmaceutical companies focusing on recyclable materials, biodegradable packaging, and innovative designs to reduce environmental impact. The market is further driven by corporate sustainability initiatives and the need for efficient supply chain solutions. Additionally, the covid-19 pandemic has accelerated the emphasis on sustainability, prompting companies to enhance their packaging strategies to align with evolving consumer preferences for eco-conscious products.
Key players in the market
Some of the key players profiled in the Sustainable Pharmaceutical Packaging Market include Amcor Plc, Mondi Plc, Gerresheimer AG, Schott AG, Berry Global, Aptar Group, West Pharmaceutical Services Inc., Becton, Dickinson and Company (BD), Sonoco Products Company, Uflex Limited, Catalent Inc., CCL Industries Inc., DS Smith Plc, Constantia Flexibles Group GmbH, ALPLA Group, Winpak Limited and Piramal Glass.
In June 2024, Gerresheimer introduced EcoLine Vials as part of its commitment to sustainability in pharmaceutical packaging. These vials are manufactured using recycled glass, specifically incorporating cullet, which is recycled glass material. The EcoLine vials maintain the high-quality standards required for pharmaceutical packaging while contributing to the global effort to minimize CO2 emissions and support a circular economy.
In June 2024, Berry Global launched its EnviroTite(TM) Rigid Tubes in June 2024. These innovative tubes are designed specifically for pharmaceutical applications, incorporating up to 100% recycled content in their composition. EnviroTite(TM) provides a sustainable solution for rigid tube packaging, aligning with the global trend toward eco-friendly packaging in the healthcare sector.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.